Monday, Oct 26, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Piramal Pharma Invests Rs 101 77 Cr In Yapan Bio

Piramal Pharma invests Rs 101.77 cr in Hyderabad-based Yapan Bio

New Delhi: Piramal Pharma on Tuesday said it has invested Rs 101.77 crore in Hyderabad-based Yapan Bio to augment the capabilities of its contract development and manufacturing organisation (CDMO) business. The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment. The investment will allow Piramal Pharma to […]

By PTI
Updated On - 21 December 2021, 04:56 PM
Piramal Pharma invests Rs 101.77 cr in Hyderabad-based Yapan Bio
Representational Image
whatsapp facebook twitter telegram

New Delhi: Piramal Pharma on Tuesday said it has invested Rs 101.77 crore in Hyderabad-based Yapan Bio to augment the capabilities of its contract development and manufacturing organisation (CDMO) business.

The Mumbai-based company has acquired a 27.78 per cent stake in Yapan as a result of the investment.


The investment will allow Piramal Pharma to strengthen Piramal Pharma Solutions (PPS), its CDMO business, by broadening its service offerings.

“The expertise found at the Yapan will help Piramal provide existing customers with wider capabilities for developing and manufacturing large molecules. This investment further supports our growth strategy,” Piramal Pharma Chairperson Nandini Piramal noted.

Yapan Bio provides process development, scale-up and cGMP compliant manufacturing of vaccines and biologics/bio-therapeutics, including high containment product classes (up to BSL-2+), recombinant vaccines, RNA/DNA vaccines, gene therapies, monoclonal antibodies, therapeutic proteins, and other complex biologics.

Its FY21 turnover stood at Rs 12.4 crore. The company has already earned revenues of Rs 11.8 crore in the first half of FY22.
“During the past decade, biologics and their accompanying development services are the fastest-growing segments of the CDMO market.

“This investment, coupled with the market-leading capabilities of our Grangemouth, UK site in antibody-drug conjugations and our sterile fill capabilities in Lexington, USA, demonstrates our commitment to growing our service offerings in the large molecule CDMO space,” Piramal Pharma Solutions CEO Peter DeYoung said.


Now you can get handpicked stories from Telangana Today on Telegram everyday. Click the link to subscribe.

Click to follow Telangana Today Facebook page and Twitter .


Join Our Whatsapp Channel
  • Follow Us :
As preferred source
  • Tags
  • Hyderabad
  • Piramal Pharma
  • Yapan Bio

Related News

  • Hyderabad birder spots returning migratory flycatcher at Ameenpur

    Hyderabad birder spots returning migratory flycatcher at Ameenpur

  • TGSRTC introduces seven-day unlimited travel pass for Rs 600

    TGSRTC introduces seven-day unlimited travel pass for Rs 600

  • Scrap dealer critically injured in explosion at Hyderabad’s Ramanthapur

    Scrap dealer critically injured in explosion at Hyderabad’s Ramanthapur

  • Hyderabad: Woman hangs self in Madhapur

    Hyderabad: Woman hangs self in Madhapur

Latest News

  • Opinion: Uncounted and Unprotected — India’s seasonal migrants and Digital Census

    5 hours ago
  • Editorial: India’s higher education: Vacant posts worsen worries

    5 hours ago
  • Kenya: At least 24 dead in bus-truck collision on Nairobi-Mombasa highway

    6 hours ago
  • Nayanthara comes on board Rajinikanth-starrer ‘Dharman’

    6 hours ago
  • Over 50,000 nominations validated for MPTC, ZPTC polls in Andhra

    6 hours ago
  • Kharge faces police complaint in Patna over controversial comment on Modi’s father

    7 hours ago
  • Students, activists stage protest in Hyderabad; seek withdrawal of SIR

    7 hours ago
  • Harmanpreet Kaur, Deepti Sharma centuries power India to ODI series win over Zimbabwe

    7 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App